RecruitingNCT04104230

Quebec Pancreas Cancer Study


Sponsor

George Zogopoulos

Enrollment

2,000 participants

Start Date

Mar 12, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

The Quebec Pancreas Cancer Study is a prospective clinic-based study consisting of clinical, family history and epidemiologic data, with accompanying biospecimens, from patients diagnosed with either pancreas cancer, a related cancer or a related pre-cancerous condition, and their families.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a database of people with pancreatic cancer or at high risk of developing it, in order to better understand who gets the disease and why. Participants contribute samples and health information for research. **You may be eligible if...** - You have been diagnosed with pancreatic cancer or a related cancer (such as bile duct, gallbladder, or duodenal cancer) - You have a pancreatic growth or cyst - You have a strong family history of pancreatic cancer (3 or more relatives affected) - You carry a gene mutation linked to hereditary cancer syndromes (such as BRCA1/2, Lynch Syndrome, Peutz-Jeghers, or CDKN2A) AND have a family history of cancer **You may NOT be eligible if...** - You carry certain hereditary cancer gene mutations (like BRCA1/2 or Lynch Syndrome) but have NO family history of cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

McGill University Health Centre

Montreal, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04104230


Related Trials